The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Codexis Inc (NASDAQ: CDXS) was $2.45 for the day, up 0.82% from the previous closing price of $2.43. In other words, the price has increased by $0.82 from its previous closing price. On the day, 0.73 million shares were traded. CDXS stock price reached its highest trading level at $2.475 during the session, while it also had its lowest trading level at $2.35.
Ratios:
Our analysis of CDXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.72. In the meantime, Its Debt-to-Equity ratio is 1.20 whereas as Long-Term Debt/Eq ratio is at 1.14.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 30 ’25 when Opaleye Management Inc. bought 25,000 shares for $2.31 per share. The transaction valued at 57,660 led to the insider holds 9,655,000 shares of the business.
Opaleye Management Inc. bought 20,000 shares of CDXS for $46,436 on May 01 ’25. The 10% Owner now owns 9,675,000 shares after completing the transaction at $2.32 per share. On Apr 25 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 25,000 shares for $2.24 each. As a result, the insider paid 55,915 and bolstered with 9,630,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 202969760 and an Enterprise Value of 202685888. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.07 while its Price-to-Book (P/B) ratio in mrq is 4.09. Its current Enterprise Value per Revenue stands at 4.069 whereas that against EBITDA is -3.266.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.53, which has changed by -0.2939481 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -0.50%, while the 200-Day Moving Average is calculated to be -29.87%.
Shares Statistics:
CDXS traded an average of 908.04K shares per day over the past three months and 619930 shares per day over the past ten days. A total of 82.84M shares are outstanding, with a floating share count of 80.50M. Insiders hold about 2.83% of the company’s shares, while institutions hold 80.12% stake in the company. Shares short for CDXS as of 1745971200 were 5686466 with a Short Ratio of 6.26, compared to 1743379200 on 5106915. Therefore, it implies a Short% of Shares Outstanding of 5686466 and a Short% of Float of 6.99.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
